Tracheostomy decreases continuous analgesia and sedation requirements

Area of Science:

• Critical Care Medicine
• Surgical Patient Management
• Pharmacology

Background:

• Sedation in critically ill surgical patients aims to reduce pain, anxiety, and agitation without compromising cardiopulmonary function.
• Tracheostomy may reduce sedation and analgesia needs, but supporting data are limited.
• This study investigated the impact of tracheostomy on sedation and analgesia requirements.

Purpose of the Study:

• To evaluate the effect of tracheostomy on the utilization of sedation, anxiolytic, and analgesic medications.
• To assess changes in patient agitation and mental status following tracheostomy.
• To determine if tracheostomy facilitates a transition from intravenous to enteral medication administration.

Main Methods:

• Retrospective review of 468 patients undergoing tracheostomy at a Level I trauma center (2013-2018).
• Analysis of Glasgow Coma Scale, Richmond Agitation-Sedation Scale, and Confusion Assessment Method scores (72 hours pre- to post-tracheostomy).
• Quantification of daily sedation, anxiolytic, and analgesic drug doses using mixed-effects models.

Main Results:

• Significant decreases in propofol, fentanyl, and midazolam utilization post-tracheostomy.
• Increased use of intermittent enteral medications like quetiapine and methadone after tracheostomy.
• Improved Richmond Agitation-Sedation Scale, Glasgow Coma Scale, and Confusion Assessment Method scores within 24 hours post-tracheostomy.

Conclusions:

• Tracheostomy enables a rapid and substantial reduction in intravenous sedation and analgesia.
• Transitioning to enteral medications post-tracheostomy may improve postoperative mental status and reduce agitation.
• Findings support tracheostomy as a strategy to optimize sedation and analgesia management in critically ill surgical patients.